CD33 Recombinant Antibody, PE-Cy7 Conjugated
Product Specifications
Background
Putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase (s) via their SH2 domain (s) that block signal transduction through dephosphorylation of signaling molecules. Induces apoptosis in acute myeloid leukemia (in vitro) .
Synonyms
CD33_HUMAN; CD 33; CD33 antigen; CD33 molecule; FLJ00391; gp67 ; Myeloid cell surface antigen CD33; Myeloid cell surface antigen CD33 precursor; p67 ; Sialic acid binding Ig like lectin 3; Sialic acid binding immunoglobulin like lectin 3; SIGLEC3; Siglec-3; myeloid cell surface antigen CD33 isoform 1 precursor.
Gene ID
945
Swiss Prot
P20138
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
CD33
Clonality
Recombinant
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human CD33
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
945
Isotype
IgG
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2085-72E 50 µg
Casein Kinase 2 beta (Protein Kinase CK2, PKCK2, CK2b, CK2 beta, CKIIb, CK2B1, CSNK2B1) discontinued. see 047580
Sign In for Pricing
View Details